These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 23520671
1. Stereotactic body radiation therapy (SBRT) for lung and liver tumours. Anand AK, Punnakal AU, Chaudhoory AR, Garg C, Munjal RK, Bansal AK, Sharma R, Kumar R, Kumar G. J Indian Med Assoc; 2012 Jul; 110(7):462-4. PubMed ID: 23520671 [No Abstract] [Full Text] [Related]
2. Translational and rotational intra- and inter-fractional errors in patient and target position during a short course of frameless stereotactic body radiotherapy. Josipovic M, Persson GF, Logadottir A, Smulders B, Westmann G, Bangsgaard JP. Acta Oncol; 2012 May; 51(5):610-7. PubMed ID: 22263924 [Abstract] [Full Text] [Related]
5. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. Nagata Y, Hiraoka M, Mizowaki T, Narita Y, Matsuo Y, Norihisa Y, Onishi H, Shirato H. Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):343-7. PubMed ID: 19735861 [Abstract] [Full Text] [Related]
9. Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning. Coon D, Gokhale AS, Burton SA, Heron DE, Ozhasoglu C, Christie N. Clin Lung Cancer; 2008 Jul 01; 9(4):217-21. PubMed ID: 18650169 [Abstract] [Full Text] [Related]
10. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation. Hodge W, Tomé WA, Jaradat HA, Orton NP, Khuntia D, Traynor A, Weigel T, Mehta MP. Acta Oncol; 2006 Jul 01; 45(7):890-6. PubMed ID: 16982555 [Abstract] [Full Text] [Related]
12. Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer. Palma D, Senan S. Curr Opin Oncol; 2011 Mar 01; 23(2):133-9. PubMed ID: 21107257 [Abstract] [Full Text] [Related]
13. Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy. Satoh Y, Nambu A, Onishi H, Sawada E, Tominaga L, Kuriyama K, Komiyama T, Marino K, Aoki S, Araya M, Saito R, Maehata Y, Oguri M, Araki T. Eur J Radiol; 2012 Nov 01; 81(11):3530-4. PubMed ID: 22178287 [Abstract] [Full Text] [Related]
15. [Cyberknife surgery with a radio-scalpel: a new treatment option for patients with unresectable metastases]. Rentsch M, Winter H, Bruns CJ, Stintzing S, Angele MK, Jauch KW, Muacevic A. Zentralbl Chir; 2010 Apr 01; 135(2):175-80. PubMed ID: 20340074 [Abstract] [Full Text] [Related]
17. Electromagnetic navigational bronchoscopy-guided fiducial markers for lung stereotactic body radiation therapy: analysis of safety, feasibility, and interfraction stability. Nabavizadeh N, Zhang J, Elliott DA, Tanyi JA, Thomas CR, Fuss M, Deffebach M. J Bronchology Interv Pulmonol; 2014 Apr 01; 21(2):123-30. PubMed ID: 24739685 [Abstract] [Full Text] [Related]
18. Stereotactic body radiotherapy for pulmonary metastases. Prognostic factors and adverse respiratory events. Inoue T, Oh RJ, Shiomi H, Masai N, Miura H. Strahlenther Onkol; 2013 Apr 01; 189(4):285-92. PubMed ID: 23420546 [Abstract] [Full Text] [Related]
19. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer. Hiraoka M, Matsuo Y, Nagata Y. Cancer Radiother; 2007 Apr 01; 11(1-2):32-5. PubMed ID: 17158081 [Abstract] [Full Text] [Related]
20. Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery: an alternative strategy. Harley DP, Krimsky WS, Sarkar S, Highfield D, Aygun C, Gurses B. Ann Thorac Surg; 2010 Feb 01; 89(2):368-73; discussion 373-4. PubMed ID: 20103300 [Abstract] [Full Text] [Related] Page: [Next] [New Search]